via The Scientist RSS https://ift.tt/IU6NHwM A first-of-its-kind gene therapy dramatically reduced misfolded protein levels in some clinical trial participants for up to six months and reduced levels in all participants for up to a year. https://ift.tt/Zq3aDUh March 02, 2022 at 10:27PM